A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma — Stella

Recruiting

Back to Hodgkin Lymphoma trials

Trial locations(1 site)

Japan

Takeda selected site, Tokyo, Tokyo

Key details

Sponsor

Takeda

Enrollment target

~8 participants

Started

August 2022

Primary completion

July 2027

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov